Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for OSR Health, Inc. (OSRH : OTC)
 
 • Company Description   
OSR Health Inc. is a healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSR Health engages in immuno-oncology, regenerative biologics and medical device technologies to improve health outcomes. OSR Health Inc., formerly known as OSR Holdings Inc., is based in BELLEVUE, WA.

Number of Employees: 4

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.20 Daily Weekly Monthly
20 Day Moving Average: 30,100,886 shares
Shares Outstanding: 35.12 (millions)
Market Capitalization: $7.09 (millions)
Beta: 0.49
52 Week High: $0.91
52 Week Low: $0.08
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -47.67% -47.29%
12 Week -45.92% -47.06%
Year To Date -64.19% -68.06%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10900 NE 4TH STREET SUITE 2300
-
BELLEVUE,WA 98004
USA		 ph: 425-635-7700
fax: -		 ir@osr-holdings.com http://www.osr-holdings.com
 
 • General Corporate Information   
Officers
Kuk Hyoun Hwang - Chief Executive Officer and Director
Gihyoun Bang - Chief Financial Officer
Seng Chin Mah - Director
Hyuk Joo Jee - Director
Hyuk Joo Jee - Director

Peer Information
OSR Health, Inc. (CORR.)
OSR Health, Inc. (RSPI)
OSR Health, Inc. (CGXP)
OSR Health, Inc. (BGEN)
OSR Health, Inc. (GTBP)
OSR Health, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 68840D102
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/11/26
Share - Related Items
Shares Outstanding: 35.12
Most Recent Split Date: (:1)
Beta: 0.49
Market Capitalization: $7.09 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/11/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.06
Price/Cash Flow: -
Price / Sales: 3.92
EPS Growth
vs. Year Ago Period: -200.00%
vs. Previous Quarter: 77.78%
Sales Growth
vs. Year Ago Period: -72.18%
vs. Previous Quarter: -34.71%
ROE
06/30/26 - -8.36
03/31/26 - -7.24
12/31/25 - -13.53
ROA
06/30/26 - -6.24
03/31/26 - -5.41
12/31/25 - -10.17
Current Ratio
06/30/26 - 0.18
03/31/26 - 0.16
12/31/25 - 0.16
Quick Ratio
06/30/26 - 0.14
03/31/26 - 0.14
12/31/25 - 0.15
Operating Margin
06/30/26 - -593.15
03/31/26 - -363.26
12/31/25 - -619.82
Net Margin
06/30/26 - -593.15
03/31/26 - -363.26
12/31/25 - -619.82
Pre-Tax Margin
06/30/26 - -974.74
03/31/26 - -814.53
12/31/25 - -994.08
Book Value
06/30/26 - 3.56
03/31/26 - 3.85
12/31/25 - 4.95
Inventory Turnover
06/30/26 - 3.26
03/31/26 - 7.84
12/31/25 - 7.02
Debt-to-Equity
06/30/26 - 0.00
03/31/26 - 0.00
12/31/25 - 0.00
Debt-to-Capital
06/30/26 - 0.22
03/31/26 - 0.21
12/31/25 - 0.00
 

Powered by Zacks Investment Research ©